-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

508. Bone Marrow Failure: Acquired: Poster III

Symposia: Bone Marrow Failure: Acquired Program: Oral and Poster Abstracts
Type: Poster
Monday, December 12, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Kinuko Mitani, MD, PhD1, Jong Wook Lee, M.D., Ph.D.2, Jun Ho Jang, MD, PhD3, Yoshiaki Tomiyama4, Koji Miyazaki, MD5, Koji Nagafuji6, Kensuke Usuki, MD, PhD7, Nobuhiko Uoshima, MD, PhD8*, Tomoaki Fujisaki9*, Hiroshi Kosugi, MD, PhD10, Itaru Matsumura11, Ko Sasaki1, Masahiro Kizaki, MD12, Masashi Sawa, MD, PhD13*, Michihiro Hidaka, MD, PhD14*, Naoki Kobayashi, MD, PhD15*, Satoshi Ichikawa, MD, PhD16*, Yuji Yonemura, MD, PhD17, Kenta Murotani, PhD18*, Mami Shimizu19*, Akira Matsuda, MD20*, Keiya Ozawa, MD21* and Shinji Nakao, MD, PhD22

1Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan
2Division of Hematology, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea, Republic of (South)
3Department of Hematology, Sungkyunkwan University Samsung Medical Center, Seoul, Korea, Republic of (South)
4Department of Blood Transfusion, Osaka University Hospital, Osaka, Japan
5Department of Transfusion and Cell Transplantation, Kitasato University School of Medicine, Sagamihara, JPN
6Kurume University Hospital, Kurume, Japan
7Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan
8Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, JPN
9Matsuyama Red Cross Hospital, Matsuyama, Japan
10Department of Hematology, Ogaki Municipal Hospital, Ogaki, Japan
11Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Osaka, Japan
12Department of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan
13Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan
14Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan
15Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan
16Department of Hematology, Tohoku University Graduate School of Medicine, Sendai, Japan
17Department of Transfusion Medicine and Cell Therapy, Kumamoto University Hospital, Kumamoto, Japan
18Biostatistics Center, Kurume University, Kurume, Japan
19Kyowa Kirin Co., Ltd., Tokyo, Japan
20Department of Hemato-Oncology, International Medical Center, Saitama Medical University, Saitama, Japan
21Division of Hematology, Jichi Medical University, Tochigi, Japan
22Division of Transfusion Medicine, Kanazawa University Hospital, Kanazawa, Japan

Bruno Fattizzo, MD1,2*, Carmelo Gurnari, MD3,4, Giulio Cassanello5*, Marta Bortolotti, MD6,7*, Hussein Awada3*, Sabrina Giammarco8*, Dario Consonni, MD9*, Simona Sica10*, Shreyans Gandhi11*, Roochi Trikha, MD, PhD12*, Jaroslaw P. Maciejewski, MD, PhD, FACP13, Austin Kulasekararaj, MD, MBBS, FRCPath, MRCP14 and Wilma Barcellini, MD15*

1Universita Degli Studi di Milano, Milano, Milano, Italy
2Hematology Unit, Pathophysiology of Anemias Unit, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
3Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
4Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy
5University of Milano, Milan, ITA
6Department of Oncology and Oncohaematology, University of Milan, Milan, Italy
7Haematology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
8Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
9Epidemiology Unit, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
10Fondazione Policlinico A. Gemelli IRCCS, Roma, Italy; Istituto di Ematologia, Università Cattolica del Sacro Cuore, Roma, Italy, Roma, Italy
11Haematological Medicine, King's College Hospital NHS Trust, London, United Kingdom
12King's College Hospital, London, United Kingdom
13Translational Hematology and Oncology Research, Cleveland Clinic Foundation/ Taussig Cancer Institute, Cleveland, OH
14King’s College Hospital, National Institute for Health and Care Research/Wellcome King’s Clinical Research Facility, London, ENG, United Kingdom
15Hematology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy

Edo Schaefer, MD1, Yanling Liao, PHD2*, Morgan Anderson-Crannage2*, Bruno Hochberg3*, Hanif Mouehla3*, Jian Pan2*, Bernadette Fallon, MT(ASCP)2*, Janet Ayello, MS, MT(ASCP)3* and Mitchell S. Cairo, MD3,4,5,6,7,8

1Pediatric Hematology, Oncology & Stem Cell Transplantation, New York Medical College, Rye, NY
2Pediatric Hematology, Oncology & Stem Cell Transplantation, New York Medical College, Hawthorne, NY
3Department of Pediatrics, New York Medical College, Valhalla, NY
4Departments of Microbiology & Immunology & Pathology, New York Medical College, Valhalla, NY
5Department of Medicine, New York Medical College, Valhalla, NY
6Pediatrics, New York Medical College, Valhalla, NY
7Immunology and Cell Therapy, New York Medical College, Valhalla, NY
8Department of Cell Biology & Anatomy, New York Medical College, Valhalla, NY

Lijie Zeng1*, Hui Liu1*, Zhaoyun Liu1*, Liyan Li1*, Zonghong Shao2 and Rong Fu1*

1Department of hematology, Tianjin Medical University General Hospital, Tianjin, China
2Department of Hematology, Tianjin Medical University General Hospital, Tianjin, China

Magali Le Garff-Tavernier1*, Jean-Philippe Vial, MD2*, Thomas Boyer, MD3*, Nicolas Chapuis, PharmD, PhD4*, Véronique Harrivel, MD5*, Anne-Catherine Lhoumeau, PhD, PharmD6*, Elsa Bera, MD7*, Isabelle Kittler8*, Marie Loosveld, MD, PhD9*, Gerard Socie, MD, PhD10, Regis Peffault De Latour11*, Bernard Drenou, MD, PhD12*, Agathe Debliquis12* and Orianne Wagner-Ballon, MD, PhD13

1Sorbonne Université-INSERM UMRS 1138, AP-HP, Hopital Pitie-Salpetriere, Service d’Hématologie Biologique, Paris, France
2Hematology Biology, Bordeaux University Hospital, Pessac, France
3UMR9020-U1277 - CANTHER, CHU Lille, Univ. Lille, INSERM, Lille, France
4Assistance Publique-Hôpitaux de Paris.Centre-Université Paris Cité, Hôpital Cochin, Laboratory of Hematology, Paris, France
5Laboratoire d'Hématologie, CHU Amiens, Amiens, France
6Cancer Biology department, Biological Hematology, Paoli-Calmettes Institut, Marseille, France
7Centre Hospitalier Universitaire de Rouen, Rouen, France
8Centre Hospitalier Universitaire La Réunion, ST PIERRE, French Southern Territories
9Hematology Laboratory, La Timone Hospital, Aix Marseille University, MARSEILLE, France
10Department of Hematology – BMT, Hopital St. Louis, Paris, France
11Assistance Publique–Hôpitaux de Paris, Saint-Louis Hospital, Université Paris Cité, Paris, France
12Department of Hematology, Hopital Emile Muller - CH de Mulhouse, Mulhouse, France
13Hematology and Immunology department, University Hospital of Henri-Mondor, Créteil Cedex, France

Hussein Awada1*, Arda Durmaz1*, Tariq Kewan, MD2*, Fauzia Ullah, MD1*, Danai Dima, MD1, Hassan Awada, MD3*, Simona Pagliuca, MD, PhD4, Manja Meggendorfer, PhD5, Torsten Haferlach, MD5, Carmelo Gurnari, MD1,6, Valeria Visconte, PhD1 and Jaroslaw P. Maciejewski, MD, PhD, FACP1

1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
2Smilow Cancer Center, Yale New Haven Hospital, New Haven, CT
3Roswell Park Comprehensive Cancer Center, Buffalo, NY
4Service d'Hématologie Clinique, Hôpital Brabois, CHRU de Nancy, Nancy, France
5MLL Munich Leukemia Laboratory, Munich, Germany
6Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy

Ruixin Li1*, Qiqiang Long2*, Yan Yang3*, Shengyun Lin4*, Jinsong Jia5*, Donghua Zhang6*, Guangsheng He7* and Jianyong Li, MD7

1The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Jiangsu, China
2Department of Hematology, the Second Hospital of Nanjing, Nanjing, China
3Department of Hematology, The First Hospital of Jilin University, Changchun, China
4Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China
5Peking University Institute of Hematology, Peking University People’s Hospital, Beijing, China
6Department of Hematology, Tongji Hospital Huazhong Univ. of Science and Technology, Wuhan, China
7Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

Jayastu Senapati, MD, MBBS, DM1*, Hagop Kantarjian, MD2, Farhad Ravandi, MD1, Courtney D. DiNardo, MD, MSCE1, Koichi Takahashi, MD, PhD3, Danielle Hammond, MD1, Koji Sasaki, MD1, Kelly S. Chien, MD1, Rashmi Kanagal-Shamanna, MD4, Uday R Popat, MD5, Sherry A. Pierce, BSN, BA1*, Elias Jabbour, MD1, Richard E Champlin, MD5, Guillermo Garcia-Manero, MD6 and Tapan M. Kadia, MD7

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
4Department of Hematopathology, The University of Texas M D Anderson Cancer Center, Houston, TX
5Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
6Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
7Department of Leukemia, MD Anderson Cancer Center, Houston, TX

Wenrui Yang*, Xu Liu*, Xin Zhao, MD*, Li Zhang*, Guangxin Peng*, Lei Ye*, Kang Zhou*, Yuan Li*, Jianping Li*, Huihui Fan*, Yang Yang*, Youzhen Xiong*, Liping Jing, MD* and Fengkui Zhang*

Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC, Tianjin, China

Laura Guadalupe Ceja Ramirez, MD1*, Abigail Daniela Vieyra1*, Jose Alvarez, MD2*, Roberta Demichelis, MD3, Martha Alvarado, MD4*, Moises Xololt, MD5*, Antonio De La Peña, MD6*, Juan Manuel Perez, MD7*, Luara Arana, MD7 and Elia Ixel Apodaca, MD, MSc1*

1Hematology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
2Hemtology, Centro Médico Nacional 20 Noviembre, Mexico City, Mexico
3Hematology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico
4Centro Medico Nacional 20 de Noviembre, Mexico City, Mexico
5Hematology, Centro Médico Nacional Siglo XXI, Mexico City, Mexico
6Hematology, Centro Mexico Nacional 20 de Noviembre, Mexico City, Mexico
7Hematology, Centro Médico Nacional 20 de noviembre, Mexico City, Mexico

Jun Ho Jang, MD, PhD1, Roberta Demichelis, MD2, Larysa Nogaieva, MD3*, Lily LL Wong, MD4*, Soo Min Lim, MD, MRCP5*, Younsoo Kim, MS6* and Jihye Park, DVM, BS6

1Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
2Hematology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico
3MI “Cherkasy ROD” of Cherkasy Regional Council, Regional Treatment and Diagnostic Hematology Center, Cherkasy, Ukraine
4Hematology Unit, Hospital Queen Elizabeth, Kota Kinabalu, Malaysia
5Department of Medicine, Hospital Sultanah Aminah, Johor Bahru, Malaysia
6Samsung Bioepis, Co., Ltd.,, Incheon, Korea, Republic of (South)

Austin Kulasekararaj, MD, MBBS, FRCPath, MRCP1, Francesco Lanza, MD2*, Alexandros Arvanitakis3*, Saskia MC Langemeijer, MD, PhD4*, Satheesh Chonat, MD5, Vincent Chow6*, Jean Pan7*, Yaneth Saportas8*, Vladimir Hanes, MD7* and Haby Henary8*

1King’s College Hospital, National Institute for Health and Care Research/Wellcome King’s Clinical Research Facility, London, ENG, United Kingdom
2Azienda Unità Sanitaria Locale della Romagna, U.O.C. di Ematologia, Ravenna, Italy
3Skånes Universitetssjukhus Malmö, Malmo, Sweden
4Department of Hematology, Radboud university medical center, Nijmegen, Netherlands
5Emory University, Aflac Cancer & Blood Disorders Center of Children’s Healthcare of Atlanta, Atlanta, GA
6Clinical Pharmacology, Modelling and Simulation, Amgen Inc., Thousand Oaks, CA
7Amgen Inc., Thousand Oaks, CA
8Amgen, Thousand Oaks, CA

Wenrui Yang*, Xin Zhao, MD*, Xu Liu*, Youzhen Xiong*, Huihui Fan*, Guangxin Peng*, Li Zhang*, Jianping Li*, Lei Ye*, Kang Zhou*, Yuan Li*, Yang Yang*, Yingchang Mi, MD, Liping Jing, MD* and Fengkui Zhang*

Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC, Tianjin, China

*signifies non-member of ASH